15
2000
Antitumor Effects of Epidermal Growth Factor Receptor Antisense Oligonucleotides in Combination with Docetaxel in Squamous Cell Carcinoma of the Head and Neck

Jennifer Rubin Grandis , Vivian Wai Yan Lui , Abbey L. Wentzel , William E. Gooding
Clinical Cancer Research 9 ( 13) 5028 -5035

35
2003
Epidermal Growth Factor Receptor-stimulated Activation of Phospholipase Cγ-1 Promotes Invasion of Head and Neck Squamous Cell Carcinoma

Stephanie D. Drenning , Francesca M. Coppelli , Jennifer Rubin Grandis , Sufi Mary Thomas
Cancer Research 63 ( 17) 5629 -5635

97
2003
Phase I Trial of Carboplatin and Etoposide in Combination with Panobinostat in Patients with Lung Cancer

Athanassios Argiris , Jill M. Siegfried , William E. Gooding , Mark A. Socinski
Anticancer Research 33 ( 10) 4475 -4482

23
2013
Human Leukocyte Antigen Class I Allelic and Haplotype Loss in Squamous Cell Carcinoma of the Head and Neck: Clinical and Immunogenetic Consequences

Stephanie D. Drenning , Jennifer Rubin Grandis , Mona F. Melhem , Penelope A. Morel
Clinical Cancer Research 6 ( 7) 2794 -2802

79
2000
Molecular Staging of Lymph Nodes from Patients with Esophageal Adenocarcinoma

Rodney J. Landreneau , James D. Luketich , Melissa L. Chestney , Sydney D. Finkelstein
Clinical Cancer Research 11 ( 3) 1099 -1109

33
2005
Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients.

James D. Luketich , Sydney D. Finkelstein , Tony E. Godfrey , William E. Gooding
Clinical Cancer Research 7 ( 12) 4041 -4048

63
2001
2
2005
PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal Cancer.

Umamaheswar Duvvuri , Robert L. Ferris , Tanya J. Rath , Barton F. Branstetter
Laryngoscope

2021
Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case‐control study

Robert L. Ferris , Yuri E. Nikiforov , Sally E. Carty , Linwah Yip
Cancer 127 ( 11) 1779 -1787

2021
Association of high circulating neuregulin-1 with clinical benefit in EGFR wild-type NSCLC patients treated with rilotumumab and erlotinib.

Laura P. Stabile , Ahmad A. Tarhini , Mariya Farooqui , Jose Gomez-Garcia
Journal of Clinical Oncology 34

2016
Inhibition of EGFR-STAT3 Signaling with Erlotinib Prevents Carcinogenesis in a Chemically-Induced Mouse Model of Oral Squamous Cell Carcinoma

Rebecca J Leeman-Neill , Raja R Seethala , Shivendra V Singh , Maria L Freilino
Cancer Prevention Research 4 ( 2) 230 -237

48
2011
39
2017
Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.

Marina N. Nikiforova , Stephanie Mercurio , Abigail I. Wald , Michelle Barbi de Moura
Cancer 124 ( 8) 1682 -1690

134
2018
Phase 1 study of EGFR‐antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives

Julie E. Bauman , Umamaheswar Duvvuri , Sufi Thomas , William E. Gooding
Cancer 124 ( 19) 3881 -3889

2
2018
Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.

Simion I. Chiosea , Lester D. R. Thompson , Ilan Weinreb , Julie E. Bauman
Cancer 122 ( 20) 3136 -3144

39
2016
Durable Complete Responses With High-Dose Bolus Interleukin-2 in Patients With Metastatic Melanoma Who Have Experienced Progression After Biochemotherapy

Ahmad A. Tarhini , John M. Kirkwood , William E. Gooding , Chao Cai
Journal of Clinical Oncology 25 ( 25) 3802 -3807

67
2007